Summary
The University of Melbourne is a research university that provides graduate, postgraduate, and research degrees. The university offers services in various fields that include arts, engineering, business and economics, architecture, building and planning, land and environment, medical, dentistry, information and technology, education, and health science, law, veterinary science, among others. It also provides awareness and management services to the society in the field of research and teaching services. The University of Melbourne’s health services comprise contraception, sexually transmitted infections, women's health, men's health, and others. It also provides research and developmental activities. UM is headquartered in Parkville, Victoria, Australia.
The University of Melbourne - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The University of Melbourne, Medical Devices Deals, 2010 to YTD 2016 9
The University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The University of Melbourne, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Hatchtech Raises US$12 Million In Venture Financing 12
Hatchtech Raises US$6.3 Million In Venture Financing 14
Hatchtech Raises US$6.3 Million In Venture Financing 16
Partnerships 18
University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 18
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 19
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 20
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 21
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 22
Janssen-Cilag Enters Into Research Agreement With University of Melbourne 23
Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 24
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 26
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 27
Western Health Forms Joint Venture With Peter MacCallum Cancer Centre 28
AB SCIEX Enters Into Co-Development Agreement With University Of Melbourne 29
Vitrolife Enters Into Collaboration Agreement With University of Melbourne 30
Licensing Agreements 31
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 31
The University of Melbourne - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
The University of Melbourne, Pharmaceuticals & Healthcare, Key Facts 1
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of Melbourne, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of Melbourne, Deals By Therapy Area, 2010 to YTD 2016 8
The University of Melbourne, Medical Devices Deals, 2010 to YTD 2016 9
The University of Melbourne, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Hatchtech Raises US$12 Million In Venture Financing 12
Hatchtech Raises US$6.3 Million In Venture Financing 14
Hatchtech Raises US$6.3 Million In Venture Financing 16
University of Melbourne Enters Into Agreement With Procypra To Develop Drugs For Neurological Diseases 18
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 19
International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 20
Servier Enters into Research Agreement with Walter and Eliza Hall Institute of Medical Research 21
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 22
Janssen-Cilag Enters Into Research Agreement With University of Melbourne 23
Servier Enters Into R&D Agreement With Florey Institute of Neuroscience and Mental Health 24
Molecular Discovery Enters Into Co Development Agreement With Peter MacCallum Cancer Centre 26
ImmusanT Enters Into Research Agreement With Walter and Eliza Hall Institute of Medical Research 27
Western Health Forms Joint Venture With Peter MacCallum Cancer Centre 28
AB SCIEX Enters Into Co-Development Agreement With University Of Melbourne 29
Vitrolife Enters Into Collaboration Agreement With University of Melbourne 30
TetraLogic Pharma Enters Into Licensing Agreement With Walter And Eliza Hall Institute Of Medical Research 31
The University of Melbourne, Key Competitors 33
The University of Melbourne, Key Employees 34
The University of Melbourne, Other Locations 35
The University of Melbourne, Subsidiaries 35
List of Figures
The University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The University of Melbourne, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The University of Melbourne, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The University of Melbourne, Medical Devices Deals, 2010 to YTD 2016 9
